Cover Image

Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy

Several new biomarkers, such as lipopolysaccharide binding protein (LBP) and interleukin-6 (IL-6), have the potential to determine the severity and outcome of infectious diseases. LBP and IL-6 serum levels have not been reported in patients with gastrointestinal infections. The aim of this study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Elsing, Christoph (Author) , Ernst, S. (Author) , Kayali, N. (Author) , Stremmel, Wolfgang (Author) , Harenberg, S. (Author)
Format: Article (Journal)
Language:English
Published: 27 April 2011
In: Infection
Year: 2011, Volume: 39, Issue: 4, Pages: 1-5
ISSN:1439-0973
DOI:10.1007/s15010-011-0117-5
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s15010-011-0117-5
Get full text
Author Notes:C. Elsing, S. Ernst, N. Kayali, W. Stremmel, S. Harenberg
Description
Summary:Several new biomarkers, such as lipopolysaccharide binding protein (LBP) and interleukin-6 (IL-6), have the potential to determine the severity and outcome of infectious diseases. LBP and IL-6 serum levels have not been reported in patients with gastrointestinal infections. The aim of this study was to compare established markers of infection with new markers, such as LBP and IL-6, in patients with acute gastrointestinal infections
Item Description:Gesehen am 28.04.2022
Physical Description:Online Resource
ISSN:1439-0973
DOI:10.1007/s15010-011-0117-5

Similar Items